Asphaug L, Akslen LA, Blix ES, Boge B, Borgen EF, Brekke MB, Falk RS, Geitvik GA, Gilje B, Gravdehaug B, Heie A, Janssen E, Kiserud CE, Kursetgjerde T, Langerød A, Lømo J, Mannsåker B, Mortensen E, Olsson P, Porojnicu AC, Raj SX, Roe OD, Russnes HEG, Skjerven HK, Songe-Møller Set al.(2025) Cost-effectiveness of Prosigna for Adjuvant Treatment Decisions in Early Breast Cancer: Healthcare Sector and Societal Perspectives Clin Breast Cancer(in press) DOI 10.1016/j.clbc.2025.04.011, PubMed 40348620
Medhus A, Schink KO, Longva AS, Engebraaten O, Berg K, Weyergang A(2025) The mechanisms of HER2 targeted ADCs are dependent on Rab GTPases Ther Adv Med Oncol, 17, 17588359251332473 DOI 10.1177/17588359251332473, PubMed 40297622
Sæter M, Johansen SH, Reinertsen KV, Thorsen L, Haugaa KH, Nilsen TS, Sarvari SI(2025) Cardiorespiratory fitness, cardiac morphology and function, and cardiovascular risk factors in long-term breast cancer survivors compared with non-cancer controls Cardiooncology, 11(1), 1 DOI 10.1186/s40959-024-00296-0, PubMed 39755716
